4:21 PM ET
10-Q
Financial Results
Lineage Cell Therapeutics Q3 2026 Results: Turns Profitable, Net Income $4.23M
For the nine months ended September 30, 2026, Lineage Cell Therapeutics reported total revenues of $4.2 million, a decrease from $7.9 million in the prior year, primarily due to lower collaboration revenues. The company significantly reduced its net loss compared to 2025, aided by a substantial $31.2 million non-cash gain from the change in fair value of warrant liabilities.
- Key figure
- Net income $4.23M